Stock Events

Polynovo Limited 

$1.42
2
+$0+0% Friday 14:09

Statistics

Day High
1.42
Day Low
1.42
52W High
1.54
52W Low
0.4
Volume
2,000
Avg. Volume
560
Mkt Cap
1.01B
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22AugConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
-0.6
-0.4
-0.2
0
Expected EPS
0.002499009810492962
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CALZF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Biotechnology
Health Technology
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Show more...
CEO
Paul Brennan
Employees
237
Country
AU
ISIN
AU000000PNV0
WKN
000A12F4T

Listings